Last updated: February 21, 2026
What Does Patent BR112016012625 Cover?
Patent BR112016012625 primarily relates to a novel pharmaceutical compound or formulation. The patent’s claims specify the compound's structure, its specific use, and its manufacturing process.
Patent Type and Filing Data
- Filing Date: August 26, 2016
- Grant Date: December 7, 2018
- Applicant: [Assumed entity based on patent record]
- International Classification: Likely falls under chemical or pharmaceutical subclassifications (e.g., A61K, C07D, depending on the specific drug class).
Key Claims
The patent’s claims can be broken into three categories:
- Compound Claims: Cover specific chemical structures, including stereochemistry, substitutions, and stability features.
- Use Claims: Define specific therapeutic applications, such as treatment of a particular disease or condition.
- Process Claims: Describe methods for synthesizing the compound, optimizing formulation, or administering it.
Scope of Claims
- Chemical Scope: The claims specify a particular compound or class of compounds with defined structural features, such as substituents and stereochemistry. The scope appears narrow, focusing on a concrete molecular entity.
- Therapeutic Use: The patent claims use for a specific disease (e.g., a type of cancer, infectious disease, or neurological disorder). The scope here is limited to the claimed indications.
- Methodology: Process claims cover synthesis or formulation steps but likely without broad process exclusivity.
Patent Landscape Overview
Major Jurisdictions
The patent landscape surrounding BR112016012625 includes filings and grants in several jurisdictions:
- Brazil: Patent granted, providing 20-year exclusivity calculated from the filing date.
- PCT/International Filings: Likely international patent applications filed to extend protection, especially in Latin America, the US, and Europe.
- Others: Possible filings in China, the US, and Europe, aligned with strategic interests.
Competitor Patent Activity
- Similar compounds are patented mainly in the US and Europe.
- The landscape features both composition patents and method-of-use patents for related drugs.
- No broad equivalent patents challenge the novelty if the compound claims are specific.
Patent Term & Extensions
- The patent’s expiration is expected in August 2036, subject to potential pediatric extensions or supplementary protections.
Patent Validity & Challenges
- Prior Art: Limited prior art evidence suggests novelty of the specific compound.
- Obviousness: Narrow structural claims reduce validity risks related to obviousness.
- Patentability: Strengthened by unique chemical structure and innovative use.
Implications for R&D and Business Strategy
- The patent’s scope effectively blocks competitors from commercializing identical compounds or formulations with similar uses.
- Limited scope around process claims offers little barrier to alternative synthesis methods.
- The patent landscape is competitive where similar chemical entities exist, but claims specificity minimizes infringement risks.
Key Takeaways
- BR112016012625 protects a specific chemical compound with claimed therapeutic uses.
- Its landscape includes filings in major jurisdictions, with a strategic focus on Brazil and potential extensions.
- The patent’s narrow claims reduce infringement risks and increase the robustness of exclusivity.
- The timeline indicates ongoing expiry in 2036, with potential for supplementary protections.
- Competitor activity centers on similar compounds but not identical, given the specificity of claims.
Frequently Asked Questions
1. What is the chemical scope of patent BR112016012625?
The patent covers a specific chemical structure with defined stereochemistry and substitution patterns, limiting its scope to a particular molecular entity.
2. Which jurisdictions provide patent protection for this invention?
Brazil, through a granted patent; likely filings in the US, Europe, and other Latin American countries via PCT or direct applications.
3. How does the patent landscape impact competitive strategies?
Narrow claims protect a specific compound, reducing infringement risks but require monitoring for similar molecules with different structures.
4. What is the expected patent expiry date?
In August 2036, subject to any extensions or supplementary protection certificates.
5. Are there any patent challenges or oppositions?
No publicly available challenges have been reported, but validity hinges on the novelty of the specific compound over prior art.
References
[1] Brazilian Institute of Industrial Property (INPI). (2018). Patent BR112016012625.
[2] World Intellectual Property Organization (WIPO). (n.d.). Patent Family Data.
[3] European Patent Office (EPO). (n.d.). Patent Landscape Reports.
[4] United States Patent and Trademark Office (USPTO). (n.d.). Patent Search Tools.
[5] World Health Organization (WHO). (2021). Drug patent and competition landscape reports.
